Before the lot ships — an independent release review of whether the records clear it.
The last decision before a lot reaches a customer is usually made by the people with the most reason to ship it. Send the lot’s release package and we judge, independently, whether how it was made, how it tested, and what it claims actually cohere — before it leaves the building.
Release is where a lot becomes someone else’s problem. Quality-unit review and approval of the batch record before release is a recurring FDA 483 theme under 21 CFR 111.123 — and it’s no longer only an inspector who asks: a retailer or a marketplace like Amazon will hold the lot or the listing until the records back it.
Whether the lot’s own records support releasing it — before it ships.
A finished lot is releasable only if its records cohere: the executed batch record has to show the lot was made and documented the way the master record requires, and the certificate of analysis has to test the finished lot against its specification with real values, not a bare “PASS.” We judge that coherence independently — how it was made, how it tested, and what it claims — and tell you whether the package supports release or whether the lot should have been held.
Product Release Review
An independent regulatory opinion on whether a finished lot’s records support releasing it — one flat fee, before you ship it.
- Batch-record review — executed BPR vs MMR
- Release-defensibility read for the lot
- Certificate of analysis vs specification
- Independent finished-lot release defensibility
- Retailer / marketplace release documentation (Amazon)
A written opinion on the lot — whether the records support releasing it, and if not, exactly what’s missing — that you can keep in the batch file. We judge the lot against the GMP rules that govern releasing it and against its own records: whether the executed batch record shows the lot was made the way the master record requires, and whether the certificate of analysis is sound and meets the finished-product specification, testing the finished lot rather than the raw material. Not the contract manufacturer reviewing its own paperwork, not an outsourced QA firm that takes over the decision, and not a lab that only generates the data — an independent verdict on the specific lot, from a firm with no stake in shipping it. It’s built to surface the lot that reads released on paper and should have been held.
The lot’s release package:
One lot, three records that don’t agree — read side by side.
A constructed teaching case: a children’s vitamin-D gummy lot, cleared for release. Each record passed its own check. Hover a marker to see what surfaces only when how it was made, how it tested, and what it claims are read against each other.
Specimen drawn from the CAPA Crunch™ case — a 40× pediatric-overdose lot that read releasableIf the records can’t support a clean opinion that the lot is releasable, you get a straight report on what’s missing instead, at the same fee. The official release decision of record stays yours — we don’t become your quality unit or sign the batch release.
Straight answers.
My contract manufacturer already releases the lot. Isn’t that enough?
They review their own paperwork and have every reason to ship it. This is an independent read of the same package from a firm with no stake in clearing the lot — and if your name is on the label, the release is your responsibility, not theirs.
Do you sign off on the release for me?
No. The official release decision of record stays yours. We give you an independent written opinion on whether the records support releasing the lot — we don’t become your quality unit, sign the batch release, or test the product.
Isn’t a CoA that says “PASS” the whole point?
Only if it tested the finished lot against the right specification, with real values. A “PASS” on a pooled average, against a mis-entered limit, or on the raw material instead of the finished product can read clean and still not support release. We check what the PASS actually rests on.
Why would I pay for this on every lot?
You wouldn’t — it’s per lot, for the ones that matter: a first commercial lot, a new site or contract manufacturer, a lot headed to a retailer or marketplace that will hold it until the documents back it, or any lot you’re not sure should ship. One held lot pays for it many times over.
What if the records don’t support release?
You get that plainly, at the same fee, with exactly what’s missing. Sometimes the answer is “hold it, and here’s why” — which is the entire value of an independent read before the lot ships, not after a complaint.
Is this legal advice?
No — it is an independent regulatory opinion, not legal counsel, and it creates no attorney-client relationship. If your question is whether a lot’s records support releasing it, that is ours.
Where to go from here.
Regulatory work product, not legal advice. A deliverable is prepared from the records you submit and is not legal counsel, not a guarantee of any regulatory or retailer outcome, and forms no attorney-client relationship. It is an independent regulatory opinion on whether a lot’s records support release — not a GMP audit, not analytical testing, not your quality unit, and not the official batch-release decision, which remains yours. Where the records provided can’t support a defensible result, we deliver a findings report on what’s missing instead. CAPA Crunch™ is a constructed teaching case; no real company or product is depicted.